Cited by 43Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsMicroRNA in disease regulation

The pro‐inflammatory microRNA miR‐155 influences fibrillar β‐Amyloid1‐42 catabolism by microglia

Open access
Aloi, Macarena S., Prater, Katherine E., Sopher, Bryce, Davidson, Stephanie, Jayadev, Suman, Garden, Gwenn A.·2021·Glia

Abstract

Microglia are the innate immune cells of the central nervous system that adopt rapid functional changes in response to Damage Associated Molecular Patterns, including aggregated β‐Amyloid (Aβ) found in Alzheimer's disease (AD). microRNAs (miRNAs) are post‐transcriptional modulators that influence the timing and magnitude of microglia inflammatory responses by downregulating the expression of inflammatory effectors. Recent studies implicate miR‐155, a miRNA known to regulate inflammatory responses, in the pathogenesis of neurodegenerative disorders including multiple sclerosis, ALS, familial Parkinson's disease, and AD. In this work, we asked if miR‐155 expression in microglia modifies cellular behaviors in response to fibrillar Aβ 1‐42 (fAβ 1‐42), in vitro. We hypothesized that in microglia, miR‐155 expression would impact the internalization and catabolism of extracellular fAβ 1‐42. Primary microglia stimulated with lipopolysaccharide demonstrate fast upregulation of miR‐155 followed by delayed upregulation of miR‐146a, an anti‐inflammatory miRNA. Conditional overexpression of miR‐155 in microglia resulted in significant upregulation of miR‐146a. Conditional deletion of miR‐155 promoted transit of fAβ 1‐42 to low‐pH compartments where catabolism occurs, while miR‐155 overexpression decreases fAβ 1‐42 catabolism. Uptake of fAβ 1‐42 across the plasma membrane increased with both up and downregulation of miR‐155 expression. Taken together, our results support the hypothesis that inflammatory signaling influences the ability of microglia to catabolize fAβ 1‐42 through interconnected mechanisms modulated by miR‐155. Understanding how miRNAs modulate the ability of microglia to catabolize fAβ 1‐42 will further elucidate the role of cellular players and molecular crosstalk in AD pathophysiology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/glia.23988

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Alexandrov P, Zhai Y, Li W, & Lukiw W (2019). Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain. Folia Neuropathologica, 57(3), 211– 219. 10.5114/fn.2019.88449 31588707 · DOI
  2. Barrientos RM, Kitt MM, Watkins LR, & Maier SF (2015). Neuroinflammation in the normal aging hippocampus. Neuroscience, 309, 84– 99. 10.1016/j.neuroscience.2015.03.007 25772789 PMC4567963 · DOI
  3. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, … Baltimore D. (2011). miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of Experimental Medicine, 208(6), 1189– 1201. 10.1084/jem.20101823 21555486 PMC3173243 · DOI · Paper page
  4. Colonna M, & Butovsky O (2017). Microglia function in the central nervous system during health and Neurodegeneration. Annual Review of Immunology, 35, 441– 468. 10.1146/annurev-immunol-051116-052358 PMC8167938 28226226 · DOI · Paper page
  5. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, … Antel JP (2012). Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia, 60(5), 717– 727. 10.1002/glia.22298 22290798 · DOI
  6. Elton TS, Selemon H, Elton SM, & Parinandi NL (2013). Regulation of the MIR155 host gene in physiological and pathological processes. Gene, 532(1), 1– 12. 10.1016/j.gene.2012.12.009 23246696 · DOI
  7. Faustino J, Chip S, Derugin N, Jullienne A, Hamer M, Haddad E, … Vexler ZS (2019). CX3CR1-CCR2-dependent monocyte-microglial signaling modulates neurovascular leakage and acute injury in a mouse model of childhood stroke. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 39(10), 1919– 1935. 10.1177/0271678X18817663 PMC6775594 30628839 · DOI
  8. Guedes JR, Custódia CM, Silva RJ, de Almeida LP, Pedroso de Lima MC, & Cardoso AL (2014). Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model. Human Molecular Genetics, 23(23), 6286– 6301. 10.1093/hmg/ddu348 24990149 · DOI · Paper page
  9. He GL, Luo Z, Yang J, Shen TT, Chen Y, & Yang XS (2016). Curcumin ameliorates the reduction effect of PGE2 on Fibrillar β-amyloid peptide (1-42)-induced microglial phagocytosis through the inhibition of EP2-PKA signaling in N9 microglial cells. PLoS One, 11(1), e0147721. 10.1371/journal.pone.0147721 26824354 PMC4732694 · DOI
  10. Henry RJ, Doran SJ, Barrett JP, Meadows VE, Sabirzhanov B, Stoica BA, … Faden AI (2019). Inhibition of miR-155 limits Neuroinflammation and improves functional recovery after experimental traumatic brain injury in mice. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 16(1), 216– 230. 10.1007/s13311-018-0665-9 30225790 PMC6361054 · DOI
  11. Hu R, Kagele DA, Huffaker TB, Runtsch MC, Alexander M, Liu J, … O'Connell RM (2014). miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity, 41(4), 605– 619. 10.1016/j.immuni.2014.09.015 25367574 PMC4657560 · DOI
  12. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, … Chen J (2012). Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke, 43(11), 3063– 3070. 10.1161/STROKEAHA.112.659656 22933588 · DOI
  13. Huang R-S, Hu G-Q, Lin B, Lin Z-Y, & Sun C-C (2010). MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. Journal of Investigative Medicine, 58(8), 961– 967. https://pubmed.ncbi.nlm.nih.gov/21030878/. 21030878
  14. Jayadev S, Case A, Alajajian B, Eastman AJ, Möller T, & Garden GA (2013). Presenilin 2 influences miR146 level and activity in microglia. Journal of Neurochemistry, 127(5), 592– 599. 10.1111/jnc.12400 23952003 PMC4346352 · DOI
  15. Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, & Miyazawa T (2014). MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease. Journal of Alzheimer's Disease: JAD, 39 (2), 253– 259. 10.3233/JAD-130932 24157723 · DOI · Paper page
  16. Lourbopoulos A, Ertürk A, & Hellal F (2015). Microglia in action: How aging and injury can change the brain's guardians. Frontiers in Cellular Neuroscience, 9, 54. 10.3389/fncel.2015.00054 25755635 PMC4337366 · DOI
  17. Lukiw WJ, Surjyadipta B, Dua P, & Alexandrov PN (2012). Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). International Journal of Biochemistry and Molecular Biology, 3(1), 105– 116. 22509485 PMC3325769
  18. Lynch MA (2009). The multifaceted profile of activated microglia. Molecular Neurobiology, 40(2), 139– 156. 10.1007/s12035-009-8077-9 19629762 · DOI
  19. Mendell JT, & Olson EN (2012). MicroRNAs in stress signaling and human disease. Cell, 148(6), 1172– 1187. 10.1016/j.cell.2012.02.005 22424228 PMC3308137 · DOI · Paper page
  20. Mitrasinovic OM, & Murphy GM Jr. (2003). Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Abeta. Neurobiology of Aging, 24(6), 807– 815. 10.1016/s0197-4580(02)00237-3 12927763 · DOI
  21. Mizuno T (2012). The biphasic role of microglia in Alzheimer's disease. International Journal of Alzheimer's Disease, 2012, 737846– 737849. 10.1155/2012/737846 PMC3357927 22655214 · DOI
  22. O'Connell RM, Rao DS, & Baltimore D (2012). microRNA regulation of inflammatory responses. Annual Review of Immunology, 30, 295– 312. 10.1146/annurev-immunol-020711-075013 22224773 · DOI
  23. O'Connell RM, Rao DS, Chaudhuri AA, & Baltimore D (2010). Physiological and pathological roles for microRNAs in the immune system. Nature Reviews. Immunology, 10(2), 111– 122. 10.1038/nri2708 20098459 · DOI
  24. O'Connell RM, Taganov KD, Boldin MP, Cheng G, & Baltimore D (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences of the United States of America, 104(5), 1604– 1609. 10.1073/pnas.0610731104 17242365 PMC1780072 · DOI · Paper page
  25. O'Loughlin E, Madore C, Lassmann H, & Butovsky O (2018). Microglial phenotypes and functions in multiple sclerosis. Cold Spring Harbor Perspectives in Medicine, 8(2), a028993. 10.1101/cshperspect.a028993 29419406 PMC5793738 · DOI
  26. Paresce DM, Ghosh RN, & Maxfield FR (1996). Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein Via a scavenger receptor. Neuron, 17(3), 553– 565. 10.1016/s0896-6273(00)80187-7. 8816718 · DOI · Paper page
  27. Ponomarev ED, Veremeyko T, & Weiner HL (2013). MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia, 61(1), 91– 103. 10.1002/glia.22363 22653784 PMC3434289 · DOI
  28. Saido TC (1998). Alzheimer's disease as proteolytic disorders: Anabolism and catabolism of beta-amyloid. Neurobiology of Aging, 19(1 Suppl), S69– S75. 10.1016/s0197-4580(98)00033-5 9562472 · DOI
  29. Su W, Aloi MS, & Garden GA (2016 Feb). MicroRNAs mediating CNS inflammation: Small regulators with powerful potential. Brain Behavior and Immunology, 52, 1– 8. 10.1016/j.bbi.2015.07.003 PMC5030842 26148445 · DOI · Paper page
  30. Su W, Hopkins S, Nesser NK, Sopher B, Silvestroni A, Ammanuel S, … Garden GA (2014). The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf. Journal of Immunology (Baltimore, Md.: 1950), 192(1), 358– 366. 10.4049/jimmunol.1301397 PMC4195583 24319262 · DOI · Paper page
  31. Su W, Kang J, Sopher B, Gillespie J, Aloi MS, Odom GL, … Garden GA (2016). Recombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microglia. Journal of Neurochemistry, 136(Suppl 1), 49– 62. 10.1111/jnc.13081 25708596 PMC4547919 · DOI
  32. Tiribuzi R, Crispoltoni L, Porcellati S, Di Lullo M, Florenzano F, Pirro M, … Orlacchio A (2014). miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiology of Aging, 35(2), 345– 356. 10.1016/j.neurobiolaging.2013.08.003 24064186 · DOI · Paper page
  33. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, … Mantyh PW (1998). Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 18(6), 2161– 2173. 10.1523/JNEUROSCI.18-06-02161.1998 9482801 PMC6792921 · DOI · Paper page
  34. Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S, Boucher JD, … Ikezu T (2015). miR-155 is essential for inflammation-induced hippocampal neurogenic dysfunction. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 35(26), 9764– 9781. 10.1523/JNEUROSCI.4790-14.2015 26134658 PMC4571507 · DOI
  35. Xu L, He D, & Bai Y (2016). Microglia-mediated inflammation and neurodegenerative disease. Molecular Neurobiology, 53(10), 6709– 6715. 10.1007/s12035-015-9593-4 26659872 · DOI
  36. Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X, & Liao YH (2012). MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One, 7(10), e46082. 10.1371/journal.pone.0046082 23091595 PMC3473054 · DOI · Paper page
  37. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, & Baltimore D (2011). NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proceedings of the National Academy of Sciences of the United States of America, 108(22), 9184– 9189. 10.1073/pnas.1105398108 21576471 PMC3107319 · DOI · Paper page
  38. Zhao Y, Jaber V, Percy ME, & Lukiw WJ (2017). A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down's syndrome (DS; trisomy 21). Journal of Nature and Science, 3(9), e446. PMC5613287 28959732
  39. Zrzavy T, Machado-Santos J, Christine S, Baumgartner C, Weiner HL, Butovsky O, & Lassmann H (2018). Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts. Brain Pathology (Zurich, Switzerland), 28(6), 791– 805. 10.1111/bpa.12583 PMC6334527 29222823 · DOI · Paper page

Cited by

Sorted by citations

Authors
Aloi, M. S., Prater, K. E., Sopher, B., Davidson, S., Jayadev, S., & Garden, G. A.
Affiliations
  • Baylor College of Medicine (US)
  • University of Washington (US)
Corresponding author
Garden, Gwenn A.
Venue
Glia
Publisher
Wiley
Published
2021-03-10
Volume
69
Issue
7
Pages
1736-1748
ISSN
  • 0894-1491 (ISSN-L)
  • 1098-1136
OpenAlex
W3135533676
Cited by
43
References
9
Citations by year
2026: 1 · 2025: 5 · 2024: 14 · 2023: 13 · 2022: 8 · 2021: 2
FWCI
3.70
Type
journal article
Language
en
Open access
Locations
  • Glia (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Howard Hughes Medical Institute (Gilliam Fellowship for Advanced Studies)
  • National Institute of General Medical Sciences (T32‐GM095421)
  • National Institute on Aging (R01‐AG051437, T32‐AG052354)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
miR-155, microglia, Alzheimer's disease, microRNA-146a, microglial inflammation, amyloid-beta uptake, lipopolysaccharide stimulation, neuroinflammation, amyloid-beta clearance
MeSH terms
Alzheimer Disease, Humans, Lipopolysaccharides, Amyloid beta-Peptides, Microglia, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review